A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer-Reference-Cited by-同舟云学术

A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer

Published:2016-08 Issue: Volume:236 Page:79-89
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Montagner Isabella Monia,Merlo Anna,Carpanese Debora,Dalla Pietà Anna,Mero Anna,Grigoletto Antonella,Loregian Arianna,Renier Davide,Campisi Monica,Zanovello Paola,Pasut Gianfranco^ORCID,Rosato Antonio

Funder

Italian Association for Cancer Research

Italian Ministry of Health

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference47 articles.

1. Interferons, interferon-like cytokines, and their receptors;Pestka;Immunol. Rev.,2004

2. Complex modulation of cell type-specific signaling in response to type I interferons;van Boxel-Dezaire;Immunity,2006

3. How cells respond to interferons;Stark;Annu. Rev. Biochem.,1998

4. Inteferons pen the JAK-STAT pathway;Schindler;Semin. Cell Dev. Biol.,2008

5. Interferons: success in anti-viral immunotherapy;Lin;Cytokine Growth Factor Rev.,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in hyaluronic acid: Bioactivity, complexed biomaterials and biological application: A review;Asian Journal of Surgery;2024-08

2. Hyaluronic Acid‐Based Bioconjugate Systems, Scaffolds, and Their Therapeutic Potential;Advanced Healthcare Materials;2023-04-16

3. A Review of Protein- and Peptide-Based Chemical Conjugates: Past, Present, and Future;Pharmaceutics;2023-02-10

4. The role of interferons in ovarian cancer progression: Hinderer or promoter?;Frontiers in Immunology;2022-12-21

5. Investigating the stabilisation of IFN-α2a by replica exchange molecular dynamics simulation;Journal of Molecular Modeling;2022-07-26